These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36073220)

  • 1. [Honokiol reduces doxorubicin-induced cardiotoxicity
    Xiong F; Liu R; Li Y; Sun N
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1205-1211. PubMed ID: 36073220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
    Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
    Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
    Tavakoli Dargani Z; Singla DK
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
    Li X; Yan A; Chang J; Li F; Zhu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):947-953. PubMed ID: 37866951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
    Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
    BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
    Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
    Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.
    Meng L; Lin H; Zhang J; Lin N; Sun Z; Gao F; Luo H; Ni T; Luo W; Chi J; Guo H
    J Mol Cell Cardiol; 2019 Nov; 136():15-26. PubMed ID: 31445005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact and related mechanism on the improvement of hyperglycemia-induced pyroptosis in H9c2 cells by mircoRNA-214].
    Wang Y; Zhao RZ; Chen PK; Xu GX; Liu ZJ; Long XP; Qiu ZM; Shi B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):820-828. PubMed ID: 31648465
    [No Abstract]   [Full Text] [Related]  

  • 9. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
    Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
    Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
    Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
    J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cynaroside regulates the AMPK/SIRT3/Nrf2 pathway to inhibit doxorubicin-induced cardiomyocyte pyroptosis.
    Zou H; Zhang M; Yang X; Shou H; Chen Z; Zhu Q; Luo T; Mou X; Chen X
    J Zhejiang Univ Sci B; 2024 Sep; 25(9):756-772. PubMed ID: 39308066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
    Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
    Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
    Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
    Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allicin protects against LPS-induced cardiomyocyte injury by activating Nrf2-HO-1 and inhibiting NLRP3 pathways.
    Sun F; Xu K; Zhou J; Zhang W; Duan G; Lei M
    BMC Cardiovasc Disord; 2023 Aug; 23(1):410. PubMed ID: 37596540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
    Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
    Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting Cardiomyocyte Pyroptosis through the SIRT1/NLRP3 Pathway.
    Tian W; Zhang P; Yang L; Song P; Zhao J; Wang H; Zhao Y; Cao L
    Am J Chin Med; 2024; 52(2):453-469. PubMed ID: 38490806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
    Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
    Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway.
    Yao M; Wang Z; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zeng W; Yang W; Liang R; Qian J
    Biomed Pharmacother; 2022 Sep; 153():113498. PubMed ID: 36076588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation.
    Cao R; Fang D; Wang J; Yu Y; Ye H; Kang P; Li Z; Wang H; Gao Q
    J Diabetes Res; 2019; 2019():4857921. PubMed ID: 31871948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.